# AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

> **NCT07533175** · PHASE3 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 630 (estimated)

## Conditions studied

- Diabetes Mellitus
- Overweight
- Obesity

## Interventions

- **DRUG:** NNC0487-0111
- **DRUG:** Placebo (matched to NNC0487-0111)

## Key facts

- **NCT ID:** NCT07533175
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-13
- **Primary completion:** 2028-05-15
- **Final completion:** 2028-08-07
- **Target enrollment:** 630 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533175, "AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07533175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*